Your browser is no longer supported. Please, upgrade your browser.
SCPS [NASD]
Scopus BioPharma Inc.
Index- P/E- EPS (ttm)-1.34 Insider Own1.80% Shs Outstand16.19M Perf Week-11.40%
Market Cap92.49M Forward P/E- EPS next Y-1.52 Insider Trans3.59% Shs Float8.31M Perf Month20.14%
Income-21.20M PEG- EPS next Q-0.23 Inst Own0.80% Short Float0.91% Perf Quarter-22.74%
Sales- P/S- EPS this Y-338.30% Inst Trans-75.31% Short Ratio0.17 Perf Half Y-50.39%
Book/sh-0.12 P/B- EPS next Y-52.20% ROA-455.70% Target Price- Perf Year-
Cash/sh0.35 P/C14.68 EPS next 5Y- ROE- 52W Range4.00 - 47.86 Perf YTD-65.43%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-89.28% Beta-
Dividend %- Quick Ratio0.80 Sales past 5Y- Gross Margin- 52W Low28.25% ATR0.48
Employees1 Current Ratio0.80 Sales Q/Q- Oper. Margin- RSI (14)46.94 Volatility7.97% 9.07%
OptionableNo Debt/Eq- EPS Q/Q-51.20% Profit Margin- Rel Volume1.16 Prev Close5.47
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume438.90K Price5.13
Recom2.00 SMA20-1.95% SMA50-1.18% SMA200-38.16% Volume510,129 Change-6.22%
Feb-16-21Initiated The Benchmark Company Speculative Buy $20
Sep-15-21 09:07AM  
Sep-14-21 09:00AM  
Sep-09-21 08:00AM  
Sep-07-21 09:15AM  
Sep-03-21 09:25AM  
Sep-02-21 09:15AM  
Jul-12-21 08:30AM  
Jun-30-21 09:30AM  
May-31-21 08:30PM  
May-26-21 07:30PM  
May-24-21 09:30AM  
Apr-26-21 09:25AM  
Mar-16-21 05:39AM  
Mar-15-21 07:00AM  
Feb-10-21 08:05PM  
Feb-08-21 07:00PM  
Jan-29-21 08:00PM  
Jan-27-21 09:20AM  
Jan-26-21 08:00PM  
Jan-19-21 07:00AM  
Dec-29-20 04:00AM  
Dec-18-20 12:12PM  
10:55AM  
Dec-17-20 12:23PM  
08:59AM  
Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor inverse agonist and inhibitor of inducible nitric oxide synthase for the treatment of systemic sclerosis. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Greenspan Ira ScottExecutive Committee ChairmanAug 27Buy4.987903,93414,640Aug 30 09:11 AM
Greenspan Ira ScottExecutive Committee ChairmanAug 27Buy4.9211054182,450Aug 30 09:11 AM
Lamstein Joshua RChairmanAug 27Buy5.002001,000119,997Aug 27 06:02 PM
Lamstein Joshua RChairmanAug 26Buy4.90200980119,797Aug 27 06:02 PM
Greenspan Ira ScottExecutive Committee ChairmanAug 24Buy4.655023382,340Aug 25 08:15 AM
Greenspan Ira ScottExecutive Committee ChairmanAug 23Buy4.415002,20582,290Aug 25 08:15 AM
Greenspan Ira ScottExecutive Committee ChairmanAug 20Buy4.234001,69281,790Aug 23 08:24 AM
Greenspan Ira ScottExecutive Committee ChairmanAug 19Buy4.042,0008,08013,850Aug 23 08:24 AM
Lamstein Joshua RChairmanAug 19Buy4.048003,232119,597Aug 23 05:55 PM
Greenspan Ira ScottExecutive Committee ChairmanAug 18Buy4.271,0004,27011,850Aug 19 06:10 PM
Greenspan Ira ScottExecutive Committee ChairmanAug 17Buy4.131,0004,13010,850Aug 19 06:10 PM
Greenspan Ira ScottExecutive Committee ChairmanJul 27Buy4.5420090881,390Jul 27 04:59 PM
Greenspan Ira ScottExecutive Committee ChairmanJul 26Buy4.781,0004,7809,850Jul 27 04:59 PM
Greenspan Ira ScottExecutive Committee ChairmanJul 26Buy4.764001,90481,190Jul 27 04:59 PM
Lamstein Joshua RChairmanJul 23Buy4.711,5007,065118,797Jul 27 04:59 PM
Greenspan Ira ScottExecutive Committee ChairmanJul 23Buy4.771,1005,2478,850Jul 27 04:59 PM
Gibson Robert JVice ChairmanFeb 25Buy9.291501,393300Feb 26 01:16 PM
Greenspan Ira ScottExecutive Committee ChairmanFeb 25Buy9.018007,2087,750Feb 26 01:21 PM
Greenspan Ira ScottExecutive Committee ChairmanFeb 24Buy9.453002,8356,950Feb 26 01:21 PM
Greenspan Ira ScottExecutive Committee ChairmanFeb 24Buy9.481151,09080,790Feb 26 01:21 PM
Gibson Robert JVice ChairmanFeb 24Buy9.461501,419150Feb 26 01:16 PM
Lamstein Joshua RChairmanFeb 23Buy9.345004,670117,297Feb 24 07:54 AM
Greenspan Ira ScottExecutive Committee ChairmanFeb 23Buy9.661,30012,5586,650Feb 24 07:46 AM
Greenspan Ira ScottExecutive Committee ChairmanFeb 23Buy9.582001,91680,675Feb 24 07:46 AM
Lamstein Joshua RChairmanFeb 22Buy9.99100999116,797Feb 23 08:04 AM
Greenspan Ira ScottExecutive Committee ChairmanFeb 22Buy10.054504,5225,350Feb 23 07:55 AM
Lamstein Joshua RChairmanFeb 19Buy10.935005,465116,697Feb 19 10:12 AM
Greenspan Ira ScottExecutive Committee ChairmanFeb 18Buy10.042,20022,0884,900Feb 18 09:22 PM
Greenspan Ira ScottExecutive Committee ChairmanFeb 17Buy9.812001,9622,700Feb 18 09:22 PM
Greenspan Ira ScottExecutive Committee ChairmanFeb 17Buy9.694754,60380,475Feb 18 09:22 PM
Greenspan Ira ScottExecutive Committee ChairmanFeb 16Buy10.202,50025,5002,500Feb 18 09:22 PM